Featured Application: Advances in Sleep Monitoring Technology. Background: SnoreLab (Version 5.3, Reviva Softworks Ltd., London, UK) is featured as the number one mobile application (app) for measuring snoring intensity and duration. The aim of this study was to conduct a comparative analysis between the results derived from SnoreLab and polysomnography (PSG). Methods: Male and female patients between 18 and 75 years of age, seeking medical counseling for suspected obstructive sleep apnea syndrome (OSAS), were considered eligible to participate in this study. Exclusion criteria were psychological or neurological disorders, drug or alcohol abuse, and inability to follow instructions. All patients underwent one overnight in-hospital PSG with simultaneous snoring recording using the SnoreLab app. Results: Nineteen patients (15 men, 4 women) aged 50.9 ± 10.5 years were included. The overall cohort exhibited a Snore Score of 24.8 ± 22.2 alongside an AHI of 15.1 ± 17.0, indicating moderate OSAS. Interestingly, elevated Snore Scores were observed in both the simple snoring (30.7 ± 19.2) and severe OSAS group (35.2 ± 21.4) (Kruskal–Wallis p-value = 0.176). The analysis of the Spearman’s test did not reveal a statistically significant correlation between PSG parameters and the Snore Score. Conclusions: While SnoreLab records snoring, it is not designed for screening sleep apnea. Although SnoreLab may not replace PSG for use in diagnosis, it could serve as a complementary tool for monitoring snoring and to improve the interaction between patients and clinicians when integrated into a suitable clinical assessment.
SnoreLab Application in the Assessment of Obstructive Sleep Apnea Syndrome: A Pilot Study
Caponio V. C. A.;
2024-01-01
Abstract
Featured Application: Advances in Sleep Monitoring Technology. Background: SnoreLab (Version 5.3, Reviva Softworks Ltd., London, UK) is featured as the number one mobile application (app) for measuring snoring intensity and duration. The aim of this study was to conduct a comparative analysis between the results derived from SnoreLab and polysomnography (PSG). Methods: Male and female patients between 18 and 75 years of age, seeking medical counseling for suspected obstructive sleep apnea syndrome (OSAS), were considered eligible to participate in this study. Exclusion criteria were psychological or neurological disorders, drug or alcohol abuse, and inability to follow instructions. All patients underwent one overnight in-hospital PSG with simultaneous snoring recording using the SnoreLab app. Results: Nineteen patients (15 men, 4 women) aged 50.9 ± 10.5 years were included. The overall cohort exhibited a Snore Score of 24.8 ± 22.2 alongside an AHI of 15.1 ± 17.0, indicating moderate OSAS. Interestingly, elevated Snore Scores were observed in both the simple snoring (30.7 ± 19.2) and severe OSAS group (35.2 ± 21.4) (Kruskal–Wallis p-value = 0.176). The analysis of the Spearman’s test did not reveal a statistically significant correlation between PSG parameters and the Snore Score. Conclusions: While SnoreLab records snoring, it is not designed for screening sleep apnea. Although SnoreLab may not replace PSG for use in diagnosis, it could serve as a complementary tool for monitoring snoring and to improve the interaction between patients and clinicians when integrated into a suitable clinical assessment.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
